Senarlo, Miguela M.

HRN: 28-68-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2026
CEFTAZIDIME 1GM (VIAL)
03/07/2026
03/14/2026
IV
2G
OD
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: